For the first time we demonstrate, using two in vivo models of curable ovarian cancer that had not been previously adapted to tissue culture, that a marked response to a clinically relevant cytotoxic anticancer agent could be achieved in the presence, and perhaps more importantly, in the absence of functional p53 where apoptosis was undetectable. Here, TP53 is linked to ovarian cancer.